Basics Mineralys Therapeutics, Inc. IPO Date: February 10, 2023 Sector: Healthcare Industry: Biotech Market Cap: $3.05B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.93% Avg Daily Range (30 D): $1.31 | 3.19% Avg Daily Range (90 D): $1.05 | 3.28% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): 1.39M Avg Daily Volume (90 D): 1.42M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 629 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $1.91M Avg Inst. Trade (90 D): $2.55M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.41M Avg Closing Trade (30 D): $5.13M Avg Closing Trade (90 D): $4.93M Avg Closing Volume: 150.03K     News Nov 7, 2025 @ 11:10 PM Data for Lorundrostat in Chronic Kidney Disease an... Source: Mineralys Therapeutics Sep 7, 2025 @ 12:23 PM These 2 Healthcare Stocks More Than Doubled Recent... Source: Cory Renauer Sep 5, 2025 @ 1:00 PM Mineralys Therapeutics Presents Subgroup Analyses ... Source: Mineralys Therapeutics Sep 3, 2025 @ 1:33 AM Mineralys Therapeutics Announces Pricing of Upsize... Source: Mineralys Therapeutics May 24, 2025 @ 8:30 AM Mineralys Therapeutics Announces Late-Breaking Pre... Source: Mineralys Therapeutics Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.52 $-.66 Diluted EPS $-.52 $-.66 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -36.93M $ -43.27M Operating Income / Loss $ $ -41.13M $ -46.75M Cost of Revenue $ $ $ Net Cash Flow $ $ 115.81M $ -63.22M PE Ratio